Xeris Biopharma Holdings, Inc. (XERS)

Xeris Biopharma Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	59.23	67.45	121.97	67.27	37.6	19.52
Short-Term Investments	10.17	5	-	35.16	96.19	56.03
Cash & Short-Term Investments	69.4	72.45	121.97	102.43	133.79	75.55
Cash Growth	5.19%	-40.60%	19.07%	-23.44%	77.09%	-32.92%
Accounts Receivable	41.14	39.2	30.83	17.46	6.88	4.69
Receivables	41.14	39.2	30.83	17.46	6.88	4.69
Inventory	45.12	38.84	24.74	18.12	8.35	2.18
Prepaid Expenses	7.14	5.78	9.29	4.59	3.2	5.07
Total Current Assets	162.8	156.26	186.82	142.6	152.21	87.48
Property, Plant & Equipment	28.37	29.18	9.51	6.63	6.71	7.85
Long-Term Investments	-	-	-	-	-	13.23
Goodwill	22.86	22.86	22.86	22.86	-	-
Other Intangible Assets	101.63	109.76	120.61	131.45	-	-
Long-Term Deferred Charges	-	-	-	-	-	0.4
Other Long-Term Assets	5.44	4.54	4.73	0.83	0.23	0.02
Total Assets	321.1	322.6	344.52	304.36	159.15	108.99
Accounts Payable	7.45	11.57	4.61	8.92	3.12	5.6
Accrued Expenses	44.06	45.66	44.09	51.17	21.07	19.49
Current Portion of Leases	6.04	3.5	1.58	-	-	-
Other Current Liabilities	18.4	34.47	23.35	18.95	4.02	2.24
Total Current Liabilities	91.01	95.19	73.62	79.04	28.21	27.34
Long-Term Debt	216.23	190.93	187.08	88.07	87.02	58.31
Long-Term Leases	33.64	34.76	9.4	-	-	-
Long-Term Deferred Tax Liabilities	-	2.27	3.52	4.94	-	-
Other Long-Term Liabilities	8.55	6.23	25.72	37.08	10.16	8.91
Total Liabilities	349.43	329.38	299.34	209.13	125.39	94.55
Common Stock	0.02	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	638.43	610.25	599.97	555.36	371.13	260.64
Retained Earnings	-666.75	-617.03	-554.77	-460.11	-337.39	-246.25
Comprehensive Income & Other	-0.02	-0.03	-0.02	-0.03	0.01	0.04
Total Common Equity	-28.32	-6.78	45.19	95.23	33.76	14.44
Shareholders' Equity	-28.32	-6.78	45.19	95.23	33.76	14.44
Total Liabilities & Equity	321.1	322.6	344.52	304.36	159.15	108.99
Total Debt	270.97	229.19	198.06	88.07	87.02	58.31
Net Cash (Debt)	-201.56	-156.74	-76.09	14.37	46.77	17.24
Net Cash Growth	-	-	-	-69.28%	171.21%	-78.64%
Net Cash Per Share	-1.40	-1.14	-0.56	0.18	1.10	0.66
Filing Date Shares Outstanding	149.08	140.45	137.29	135.52	59.76	37.57
Total Common Shares Outstanding	149	138.13	136.27	124.87	59.61	27.21
Working Capital	71.79	61.07	113.2	63.56	124.01	60.15
Book Value Per Share	-0.19	-0.05	0.33	0.76	0.57	0.53
Tangible Book Value	-152.81	-139.41	-98.28	-59.08	33.76	14.44
Tangible Book Value Per Share	-1.03	-1.01	-0.72	-0.47	0.57	0.53
Machinery	6.08	5.65	5.68	5.43	4.32	4.45
Leasehold Improvements	6.06	5.98	5.07	5.03	4.63	4.54

Source: S&P Capital IQ. Standard template. Financial Sources.